Literature DB >> 17451907

In vivo MRI reveals the dynamics of pathological changes in the brains of cathepsin D-deficient mice and correlates changes in manganese-enhanced MRI with microglial activation.

Aleksi Haapanen1, Usama Abo Ramadan, Taina Autti, Raimo Joensuu, Jaana Tyynelä.   

Abstract

Cathepsin D (CTSD; EC 3.4.23.5) is essential for normal development and/or maintenance of neurons in the central nervous system: its deficiency causes a devastating neurological disorder with severely shortened life span in man, sheep and mouse. Neuropathologically, the CTSD deficiencies are characterized by selective neuronal degeneration, gliosis and accumulation of autofluorescent proteinaceous storage material in neurons. Our aim was to study the dynamics behind the pathological alterations occurring in the brains of CTSD-deficient (CTSD-/-) mice by using in vivo magnetic resonance imaging (MRI) and histology. In order to do this, we measured T(2) signal intensity (SI), apparent diffusion coefficient, area and volume of multiple brain structures from MR images acquired using T(2)-, T(1)- and diffusion-weighted sequences at three time points during disease progression. MRI revealed no differences in the brains between CTSD-/- and control mice at postnatal day 15+/-1 (P15+/-1), representing an initial stage of the disease. In the intermediate stage of the disease, P19(+/-1), SI alterations in the thalami of the affected mice became evident in both T(1)- and T(2)-weighted images. The terminal stage of the disease, P25, was characterized by marked alterations in the T(2) SI, apparent diffusion coefficient and volume of multiple brain structures in CTSD-/- mice. In addition, manganese enhanced high-resolution T(1)-weighted 3D sequences (MEMRI) and histological stainings revealed that the hyperintense signal areas in MEMRI matched perfectly with areas of microglial activation in the brains of CTSD-/- mice at the terminal disease stage. In conclusion, the SI alterations in the thalami of CTSD-/- mice preceded other changes, and the degenerative process was greatly enhanced at the age P19(+/-1), leading to severely reduced brain volume in just 6 days.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451907     DOI: 10.1016/j.mri.2007.03.012

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  10 in total

Review 1.  Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.

Authors:  Katherine E Olson; Aditya N Bade; Charles R Schutt; Jingdong Dong; Scott J Shandler; Michael D Boska; R Lee Mosley; Howard E Gendelman; Yutong Liu
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

2.  Morphologic and functional correlates of synaptic pathology in the cathepsin D knockout mouse model of congenital neuronal ceroid lipofuscinosis.

Authors:  Sabine Koch; Svetlana M Molchanova; Ann K Wright; Andrew Edwards; Jonathan D Cooper; Tomi Taira; Thomas H Gillingwater; Jaana Tyynelä
Journal:  J Neuropathol Exp Neurol       Date:  2011-12       Impact factor: 3.685

3.  In vivo visualization of reactive gliosis using manganese-enhanced magnetic resonance imaging.

Authors:  Yuko Kawai; Ichio Aoki; Masahiro Umeda; Toshihiro Higuchi; Jeff Kershaw; Makoto Higuchi; Afonso C Silva; Chuzo Tanaka
Journal:  Neuroimage       Date:  2009-11-10       Impact factor: 6.556

4.  JNCL patients show marked brain volume alterations on longitudinal MRI in adolescence.

Authors:  Taina H Autti; Janne Hämäläinen; Minna Mannerkoski; Koen Van Van Leemput; Laura E Aberg
Journal:  J Neurol       Date:  2008-07-17       Impact factor: 4.849

5.  Hollow manganese oxide nanoparticle-enhanced MRI of hypoxic-ischaemic brain injury in the neonatal rat.

Authors:  Tae Yeon Jeon; Ji Hye Kim; Geun Ho Im; Jae-Hun Kim; Jehoon Yang; So-Young Yoo; Jung Hee Lee
Journal:  Br J Radiol       Date:  2016-09-21       Impact factor: 3.039

6.  Improved visualization of neuronal injury following glial activation by manganese enhanced MRI.

Authors:  Aditya N Bade; Biyun Zhou; Adrian A Epstein; Santhi Gorantla; Larisa Y Poluektova; Jiangtao Luo; Howard E Gendelman; Michael D Boska; Yutong Liu
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-01       Impact factor: 4.147

Review 7.  Applications of Manganese-Enhanced Magnetic Resonance Imaging in Ophthalmology and Visual Neuroscience.

Authors:  Wenyu Deng; Muneeb A Faiq; Crystal Liu; Vishnu Adi; Kevin C Chan
Journal:  Front Neural Circuits       Date:  2019-05-14       Impact factor: 3.492

8.  Combining systemic and stereotactic MEMRI to detect the correlation between gliosis and neuronal connective pathway at the chronic stage after stroke.

Authors:  Xiao-Zhu Hao; Le-Kang Yin; Xiao-Xue Zhang; Jia-Qi Tian; Chan-Chan Li; Xiao-Yuan Feng; Min Jiang; Yan-Mei Yang
Journal:  J Neuroinflammation       Date:  2016-06-18       Impact factor: 8.322

9.  Cathepsin D deficiency delays central nervous system myelination by inhibiting proteolipid protein trafficking from late endosome/lysosome to plasma membrane.

Authors:  Da-Zhi Guo; Lin Xiao; Yi-Jun Liu; Chen Shen; Hui-Fang Lou; Yan Lv; Shu-Yi Pan
Journal:  Exp Mol Med       Date:  2018-03-16       Impact factor: 8.718

10.  Rapid and Progressive Loss of Multiple Retinal Cell Types in Cathepsin D-Deficient Mice-An Animal Model of CLN10 Disease.

Authors:  Mahmoud Bassal; Junling Liu; Wanda Jankowiak; Paul Saftig; Udo Bartsch
Journal:  Cells       Date:  2021-03-21       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.